The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Abstract
Inhibition of the tissue factor pathway has been shown to attenuate the activation of coagulation and to prevent death in a gram-negative bacteremia primate model of sepsis. It has been suggested that tissue factor influences inflammatory cascades other than the coagulation system. The authors sought to determine the effects of 2 different doses of recombinant tissue factor pathway inhibitor (TFPI) on endotoxin-induced coagulant, fibrinolytic, and cytokine responses in healthy humans. Two groups, each consisting of 8 healthy men, were studied in a double-blind, randomized, placebo-controlled crossover study. Subjects were studied on 2 different occasions. They received a bolus intravenous injection of 4 ng/kg endotoxin, which was followed by a 6-hour continuous infusion of TFPI or placebo. Eight subjects received 0.05 mg/kg per hour TFPI after a bolus of 0.0125 mg/kg (low-dose group), and 8 subjects received 0.2 mg/kg per hour after a bolus of 0.05 mg/kg (high-dose group). Endotoxin injection induced the activation of coagulation, the activation and subsequent inhibition of fibrinolysis, and the release of proinflammatory and antiinflammatory cytokines. TFPI infusion induced a dose-dependent attenuation of thrombin generation, as measured by plasma F1 + 2 and thrombin–antithrombin complexes, with a complete blockade of coagulation activation after high-dose TFPI. Endotoxin-induced changes in the fibrinolytic system and cytokine levels were not altered by either low-dose or high-dose TFPI. The authors concluded that TFPI effectively and dose-dependently attenuates the endotoxin-induced coagulation activation in humans without influencing the fibrinolytic and cytokine response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
van Deventer, S., Buller, H., ten Cate, J., Aarden, L., Hack, C., & Sturk, A. (1990) · Blood · doi:10.1182/blood.v76.12.2520.2520 · Cited by 851
Self-citationSeptic Shock, Multiple Organ Failure, and Disseminated Intravascular Coagulation
Fourrier, F., Chopin, C., Goudemand, J., Hendrycx, S., Caron, C., Rime, A., Marey, A., & Lestavel, P. (1992) · Chest · doi:10.1378/chest.101.3.816 · Cited by 708
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey, A. A., Chang, A. C., Feigen, L., Wün, T. C., Taylor, F. B., & Hinshaw, L. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116529 · Cited by 547
Self-citationGirard, T. J., Warren, L. A., Novotny, W. F., Likert, K. M., Brown, S. G., Miletich, J. P., & Broze, G. J. (1989) · Nature · doi:10.1038/338518a0 · Cited by 479
Suffredini, A. F., Harpel, P. C., & Parrillo, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201802 · Cited by 476
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
Taylor, F. B., Chang, A. C. K., Ruf, W., Morrissey, J. H., Hinshaw, L. B., Catlett, R., Blick, K. E., & Edgington, T. S. (1991) · PubMed · Cited by 434
Cited by
Levi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
Self-citationBidirectional Relation Between Inflammation and Coagulation
Levi, M., van der Poll, T., & Büller, H. R. (2004) · Circulation · doi:10.1161/01.cir.0000131660.51520.9a · Cited by 941
Self-citationInflammation, endothelium, and coagulation in sepsis
Schouten, M., Wiersinga, W. J., Levi, M., & van der Poll, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607373 · Cited by 629
Self-citationJackson, S. P., Darbousset, R., & Schoenwaelder, S. M. (2019) · Blood · doi:10.1182/blood-2018-11-882993 · Cited by 616
Disseminated intravascular coagulation
Gando, S., Levi, M., & Toh, C.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.37 · Cited by 572
Self-citation
Metadata
- Authors
- de Jonge, E., Dekkers, P. E. P., Creasey, A. A., Hack, C. E., Paulson, S. K., Karim, A., Kesecioglu, J., Levi, M., van Deventer, S. J. H., & van der Poll, T.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-02-15
- Volume
- 95
- Issue
- 4
- Pages
- 1124-1129
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1932895848
- Cited by
- 259
- References
- 36
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. https://app.cochat.ai/papers/10.1182/blood.v95.4.1124.002k20_1124_1129
- The paper
- de Jonge, E., Dekkers, P. E. P., Creasey, A. A., Hack, C. E., Paulson, S. K., Karim, A., Kesecioglu, J., Levi, M., van Deventer, S. J. H., & van der Poll, T. (2000). Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood. https://doi.org/10.1182/blood.v95.4.1124.002k20_1124_1129
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.